Latigo Biotherapeutics Inc. (LTGO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Latigo Biotherapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$15.83
+4.08% today
Market cap
$1.0B
Overall quality
—
Kronos AI 30-day
+29.5%
8 of 8 simulated paths end higher
Latigo Biotherapeutics Inc. (LTGO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.0B. It trades at $15.83, up 4.08% today. 3 analysts' average target of $57.67 implies +264.3% from today's price. Kronos AI's 30-day forecast is +29.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $57.67 |
| Low – high | $50.00 – $73.00 |
| Analysts | 3 |
| Upside to average | +264.3% |
Kronos AI 30-day forecast
| Expected close | $19.70 (+29.5%) |
| Likely range | +13.6% … +38.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.